Clinical Trial Update: A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old [Phase 1]

View source ↗

Summary

Phase 1 study to assess how BIIB141 (Omaveloxolone) is processed in the body and its safety in children ages 2 to 15 with Friedreich's Ataxia; currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• BIIB141 (Omaveloxolone) (Omaveloxolone)

Snippet

Sponsor: Biogen | Conditions: Friedreich Ataxia | Phase 1 | Status: RECRUITING